Menu closed
A man in a park smiling and looking off into the distance.

Support is here

Support is here

Resources to guide you on your Zepbound journey—from start to finish

A mobile phone with an envelope indicating the delivery of information

Zepbound tips

Timely tips, facts, and inspiration

Get emails or texts on all things Zepbound so you can navigate your weight loss journey with greater confidence and support.

An illustration of a doctor and patient speaking with each other

Doctor discussion guide

Your weight loss journey: it’s personal

Let’s get you ready to talk about your specific weight loss goals with your doctor. From questions you may want to ask your doctor to questions they may ask you, our Doctor Discussion Guide can help you feel confident and prepared to talk about Zepbound and weight management.

A GPS pin that reads: START HERE

Digital starter kit

Get your free digital starter kit

Text "ZB" to 85099 to access your kit and learn about starting on Zepbound.

Zepbound pen

How-to video

Learn how to use the Zepbound pen.

Get all of the details in our video below or in the Instructions for Use.

Iconography of three people with green stars above their heads.

Zepbound patient experiences

Watch real Zepbound stories that highlight different people’s journeys with Zepbound.

Advocacy & Support

The greater weight-management support system

For additional support, information, and resources—including tools to advocate for improved access to care—visit the websites of these leading organizations in obesity care and advocacy.

The mission of the Obesity Action Coalition (OAC) is to elevate and empower people living with obesity through education, advocacy, and support. The organization strives to create a society where:

  • All people are treated with respect—without discrimination or bias—regardless of their size or weight
  • People living with obesity have the right to access safe and effective treatment options
  • All people understand that when it comes to health, Your Weight Matters

The OAC also has a collection of resources to help you advocate for access to obesity care, including sample letters to write to your employer and sample letters to write to your insurance company to advocate for broader access to AOMs.

The American Diabetes Association provides tools and resources for those living with diabetes or at risk for diabetes. The chronic disease of obesity is a key risk factor for diabetes, so we work to improve individual health and access to care for both diabetes and obesity. To learn more, visit

The Obesity Medicine Association (OMA) stands as the largest organization composed of physicians, nurse practitioners, physician assistants, and healthcare providers dedicated to enhancing the well-being of individuals impacted by obesity. OMA members are clinical experts in the field of obesity medicine, employing a comprehensive, scientific, and personalized approach to address this condition and help patients to achieve their health and weight objectives.

OMA supports advocacy initiatives at both national and state levels to increase access to and coverage of obesity treatment services for individuals affected by obesity. OMA is part of the Obesity Care Continuum and the Obesity Care Advocacy Network. They also hold a seat in the American Medical Association (AMA) House of Delegates and organize a biannual Obesity Caucus at AMA meetings.

Locate a healthcare provider in your area, find resources to advocate for coverage and learn about OMA’s Obesity Pillars, the open access journal of the organization.

Other product/company names mentioned herein are the trademarks of their respective owners.



Warnings - Zepbound may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.

  • Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
  • Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use Zepbound if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound.

Zepbound may cause serious side effects, including:

Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Zepbound. Tell your healthcare provider if you have stomach problems that are severe or will not go away.

Kidney problems (kidney failure). Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration.

Gallbladder problems. Gallbladder problems have happened in some people who use Zepbound. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), or clay-colored stools.

Inflammation of the pancreas (pancreatitis). Stop using Zepbound and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.

Serious allergic reactions. Stop using Zepbound and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, or very rapid heartbeat.

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Zepbound with medicines that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery.

Changes in vision in patients with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Zepbound.

Depression or thoughts of suicide. You should pay attention to changes in your mood, behaviors, feelings or thoughts. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.

Common side effects

The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of Zepbound. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.

Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or

Before using Zepbound

  • Your healthcare provider should show you how to use Zepbound before you use it for the first time.
  • Tell your healthcare provider if you are taking medicines to treat diabetes including insulin or sulfonylureas which could increase your risk of low blood sugar. Talk to your healthcare provider about low blood sugar levels and how to manage them.
  • If you take birth control pills by mouth, talk to your healthcare provider before you use Zepbound. Birth control pills may not work as well while using Zepbound. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Zepbound and for 4 weeks after each increase in your dose of Zepbound.

Review these questions with your healthcare provider:

❑ Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?

❑ Do you take diabetes medicines, such as insulin or sulfonylureas?

❑ Do you have a history of diabetic retinopathy?

❑ Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?

❑ Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Zepbound may harm your unborn baby. Tell your healthcare provider if you become pregnant while using Zepbound. It is not known if Zepbound passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using Zepbound.

  • Pregnancy Exposure Registry: There will be a pregnancy exposure registry for women who have taken Zepbound during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry, or you may contact Lilly at 1-800-LillyRx (1-800-545-5979).

How to take

  • Read the Instructions for Use that come with Zepbound.
  • Use Zepbound exactly as your healthcare provider says.
  • Zepbound is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm.
  • Use Zepbound 1 time each week, at any time of the day.
  • Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
  • If you take too much Zepbound, call your healthcare provider, seek medical advice promptly, or contact a Poison Center expert right away at 1-800-222-1222.

Learn more

Zepbound is a prescription medicine. For more information, call 1-800-LillyRx (1-800-545-5979).

This summary provides basic information about Zepbound but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Zepbound and how to take it. Your healthcare provider is the best person to help you decide if Zepbound is right for you.


Zepbound® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.


Zepbound® (ZEHP-bownd) is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. It should be used with a reduced-calorie diet and increased physical activity.

  • Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if Zepbound can be used in people who have had pancreatitis. It is not known if Zepbound is safe and effective for use in children under 18 years of age.